Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan 15;58(1):88-89.
doi: 10.1007/s13312-021-2109-6.

Beneficial Response to Phosphate Lowering Therapy in Normophosphatemic Tumoral Calcinosis

Affiliations
Case Reports

Beneficial Response to Phosphate Lowering Therapy in Normophosphatemic Tumoral Calcinosis

Sarayu Soumya et al. Indian Pediatr. .
No abstract available

PubMed Disclaimer

References

    1. Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E. Calcinosis cutis, part I: Diagnostic pathway. J Am Acad Dermatol. 2011;65:1–14. doi: 10.1016/j.jaad.2010.08.038. - DOI - PubMed
    1. Smack D, Norton SA, Fitzpatrick JE. Proposal for a pathogenesis-based classification of tumoral calcinosis. Int J Dermatol. 1996;35:265–71. doi: 10.1111/j.1365-4362.1996.tb02999.x. - DOI - PubMed
    1. Hershkovitz D, Gross Y, Nahum S, et al. Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. J Invest Dermatol. 2011;131:662–69. doi: 10.1038/jid.2010.387. - DOI - PMC - PubMed
    1. Ichikawa S, Baujat G, Seyahi A, et al. Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations. Am J Med Genet A. 2010;152A:896–903. doi: 10.1002/ajmg.a.33337. - DOI - PMC - PubMed
    1. Balachandran K, Kamalanathan S, Sahoo JP, Das AK, Halanaik D. Differential response of idiopathic sporadic tumoral calcinosis to bisphosphonates. Indian J Endocr Metab. 2014;18:521–25. doi: 10.4103/2230-8210.137511. - DOI - PMC - PubMed

Supplementary concepts

LinkOut - more resources